Cedar Brook Financial Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $366K | Sell |
|
|||||
|
2024
Q1 | $1.2M | Buy |
|
|||||
|
2023
Q4 | $942K | Sell |
|
|||||
|
2023
Q3 | $859K | Sell |
|
|||||
|
2023
Q2 | $1.04M | Buy |
|
|||||
|
2023
Q1 | $596K | Sell |
|
|||||
|
2022
Q4 | $650K | Sell |
|
|||||
|
2022
Q3 | $620K | Sell |
|
|||||
|
2022
Q2 | $759K | Sell |
|
|||||
|
2022
Q1 | $713K | Sell |
|
|||||
|
2021
Q4 | $717K | Buy |
|
|||||
|
2021
Q3 | $522K | Sell |
|
|||||
|
2021
Q2 | $541K | Buy |
|
|||||
|
2021
Q1 | $432K | Buy |
|
|||||
|
2020
Q4 | $252K | Buy |
|
|||||
|
2020
Q3 | $205K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $210K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $232K | Buy |
|